Monovisc

Monovisc is a premium viscosupplement indicated for the treatment of pain caused by osteoarthritis of the knee, specifically designed for patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics. As a high-molecular-weight hyaluronic acid injection, it acts as a biocompatible lubricant and shock absorber within the joint. By restoring the natural viscoelasticity of the synovial fluid, Monovisc helps to reduce friction and alleviate the debilitating discomfort associated with joint degeneration, allowing patients to regain mobility and improve their quality of life.

What distinguishes Monovisc is its advanced single-injection delivery system, which provides a concentrated dose of non-animal sourced hyaluronic acid in a single clinical visit. This streamlined approach offers exceptional convenience and effectiveness, reducing the need for multiple injections while maintaining a high safety profile. Engineered for long-lasting durability, Monovisc provides sustained relief from osteoarthritic symptoms, making it a trusted choice for orthopedic specialists and sports medicine professionals seeking a non-surgical intervention for chronic knee pain and joint dysfunction.